Iart Luca Shytaj

Lecturer

University of Bristol

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Iart Luca Shytaj is a Lecturer at the University of Bristol in the United Kingdom. His research focuses on virology, particularly in relation to HIV and COVID-19, as evidenced by his recent articles on HIV integration mechanisms and antiviral strategies against SARS-CoV-2. He is also involved in exploring therapeutic interventions and dendritic cell therapy for HIV treatment.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Xinlai Cheng

GERMANY

View details

Sergi Padilla-Parra

King’s College London

UNITED KINGDOM

View details

Jane McKeating

Professor

University of Oxford

UNITED KINGDOM

View details

Vibor Laketa

Head of Infectious Diseases Imaging Platform (IDIP)

Ruprecht Karls Universität Heidelberg

GERMANY

View details

Julia Maria Adler

Charité - Universitätsmedizin Berlin

GERMANY

View details

Oliver T Fackler

GERMANY

View details

Liv Zimmermann

Heidelberg University

GERMANY

View details

Inês de Castro

Lecturer

Brunel University London

UNITED KINGDOM

View details

Lishomwa Ndhlovu

Professor

Weill Cornell Medical College

UNITED STATES

View details

Mirko Cortese

Associate Professor

Università degli studi della Campania Luigi Vanvitelli Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farm

ITALY

View details

Petr Chlanda

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Iart Luca Shytaj

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening

Aquarius helicase facilitates HIV-1 integration into R-loop enriched genomic regions

Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV

Fast pH‐Driven Solubilization Method of Realgar (As 4 S 4 ) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro

A scalable workflow to test “shock and kill” therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo

Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains.

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir to Inhibit SARS-CoV-2 Replication in Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment

Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress

Patient-derived HIV-1 Nef alleles reveal uncoupling of CD4 downregulation and SERINC5 antagonism functions of the viral pathogenesis factor.

Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor

Alterations of redox and iron metabolism accompany the development of HIV latency

NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice

Collaborators (11)

Xinlai Cheng

Sergi Padilla-Parra

Jane McKeating

Vibor Laketa

Julia Maria Adler

Oliver T Fackler

Liv Zimmermann

Inês de Castro

Lishomwa Ndhlovu

Mirko Cortese

Petr Chlanda

Make your next move.